Krsnaa Diagnostics Limited (BOM:543328)

Market Cap	21.69B -16.2%
Revenue (ttm)	7.66B +9.9%
Net Income	803.87M +6.3%
EPS	24.46 +7.2%
Shares Out	n/a
PE Ratio	26.98
Forward PE	21.06
Dividend	2.75 (0.41%)
Ex-Dividend Date	Sep 12, 2025

Volume	2,818
Average Volume	7,818
Open	690.00
Previous Close	675.50
Day's Range	664.95 - 694.85
52-Week Range	628.00 - 891.80
Beta	n/a
RSI	32.93
Earnings Date	Feb 5, 2026

About Krsnaa Diagnostics

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves indivi...

• Industry: Medical Laboratories
• Founded: 2010
• Employees: 3,471
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543328

Financial Performance

In fiscal year 2025, Krsnaa Diagnostics's revenue was 7.17 billion, an increase of 15.74% compared to the previous year's 6.20 billion. Earnings were 776.08 million, an increase of 36.54%.